The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Palekhov A.V.

Russian Association of Palliative Medicine, Stavropol, Russia

Novikov G.A.

Russian University of Medicine, Moscow, Russia

Palliative care for patients with chronic pain: challenges and prospects

Authors:

Palekhov A.V., Novikov G.A.

More about the authors

Journal: Russian Journal of Pain. 2026;24(1): 53‑63

Read: 817 times


To cite this article:

Palekhov AV, Novikov GA. Palliative care for patients with chronic pain: challenges and prospects. Russian Journal of Pain. 2026;24(1):53‑63. (In Russ.)
https://doi.org/10.17116/pain20262401153

Recommended articles:
High-flow nasal cannula therapy in patients with COPD. Journal of Respiratory Medi­cine. 2025;(2):17-38
Novel opioids in postoperative pain mana­gement. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):78-84

References:

  1. Federal Law of November 21, 2011 No. 323-FZ (as amended on December 25, 2023) “On the Fundamentals of Protecting the Health of Citizens in the Russian Federation” (as amended and supplemented, entered into force on January 05, 2024), Art. 36. (In Russ.).
  2. Order of the Ministry of Health of the Russian Federation and the Ministry of Labor and Social Protection of the Russian Federation dated April 14, 2025 No. 208n/243n “On approval of the Regulation on the organization of the provision of palliative medical care, including the procedure for interaction between medical organizations, social service organizations and public associations, and other non-profit organizations operating in the field of health care”, Appendix No. 14. (In Russ.).
  3. UNODC. World Drug Report 2023. United Nations publication, 2023. (In Russ.).
  4. Clinical guidelines “Chronic pain syndrome (CPS) in adult patients requiring palliative care”, 2023. Approved by the Russian Ministry of Health. (In Russ.). https://www.consultant.ru/document/cons_doc_LAW_440320
  5. Supplement to the Board’s annual report for 2022 on the availability of internationally controlled substances. Author: International Narcotics Control Board. ISBN (Russian PDF): 9789210025102. https://doi.org/10.18356/9789210025102
  6. Nevzorova DV, Abuzarova GR, Kudrina OYu, Ustinova AI. Fundamental principles of palliative medical care. National guidelines for palliative medical care in oncology. Edited by Academician of the Russian Academy of Sciences, Professor Kaprin AD. Moscow: Molodaya gvardiya; 2022:5-11. (In Russ.).
  7. Fundamentals of palliative care. Twycross R, Wilcock E, eds. Translated from English by Erokhin VV, Yunusov GSh. Charitable foundation for hospice care “Vera”; 2020:456. (In Russ.).
  8. Hospices. Collection of materials: literature review, recommendations and reference materials. 2nd edition, corrected and supplemented. Moscow: Charitable Foundation for Assistance to Hospices “Vera”; 2011:10. ISBN 978-5-905700-02-6. (In Russ.).
  9. Abuzarova GR, Alekseeva GS, Nevzorova DV, Sarmanaeva RR, Bychkova NM, Kuznetsov SV. Personalized therapy as a new strategy for treating chronic pain in oncology. Russian Journal of Pain. 2021;1:51-52. (In Russ.). https://doi.org/10.17116/pain20211901146
  10. Novikov GA, Osipova NA, Vaisman MA, Rudoy SV, Prokhorov BM, Shumilov EI. Means and methods of long-term pain relief in patients with widespread forms of malignant neoplasms. Russian Journal of Anesthesiology and Reanimatology. 2003;(5):67-70. (In Russ.).
  11. Novikov GA, Vaisman MA, Rudoy SV. Treatment of chronic pain in palliative medicine. In: Organization of pain care in the Russian Federation. Moscow: Media Sphera; 2020:49-65. (In Russ.).
  12. Osipova NA. The problem of tolerance and dependence in the clinical use of opiates and opioids in anesthesiology and resuscitation. Russian Journal of Anesthesiology and Reanimatology. 1996;(4):17-21. (In Russ.).
  13. Osipova NA, Abuzarova GR, Petrova VV. Principles of using analgesics for acute and chronic pain. Moscow: P.A. Herzen Moscow Oncology Research Institute; 2010;38. ISBN 9785-85502-077-0. (In Russ.).
  14. Osipova NA, Novikov GA. Opioid therapy of chronic pain at the present stage. Medical, legal, organizational, economic aspects. Palliative Medicine and Rehabilitation. 2017;1:5-9. (In Russ.).
  15. Palekhov AV, Osipova NA. Ways to solve the main problems of using narcotic analgesics. Pain. 2008;4:31-37. (In Russ.).
  16. Palekhov AV, Vvedenskaya ES. Problems of legislative regulation and use of opioid analgetics in clinical practice. Russian Journal of Pain. 2019;17(2):51-60. (In Russ.).
  17. Palekhov AV. Choice of opioid pain therapy as a criterion for the quality of palliative care. Palliative Medicine and Rehabilitation. 2013;3:23-26. (In Russ.).
  18. Palekhov AV. Narcotic drugs in Russia. Doctor. 2013;4:2-5. (In Russ.).
  19. Palekhov AV, Vvedenskaya ES, Pchelintsev MV. Problems of using opioid analgesics in clinical practice: today’s requirements. In :Organization of pain care in the Russian Federation. Moscow: Media Sphera; 2020:68-72. (In Russ.).
  20. Pilipenko PI, Voitsitsky VE, Dobresko YuA. Neuroinflammation and chemically induced peripheral neuropathy. Siberian Scientific Medical Journal. 2022;42(2):4-9. (In Russ.).
  21. Pyadushkina EA, Derkach EV, Palekhov AV. Analysis of social and economic aspects of the use of prolonged forms of opioid analgesics in the treatment of chronic pain syndrome in patients with cancer. Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology. 2023;16(2):236-247. (In Russ.).
  22. Pyatnitskaya IN. General and private narcology. Guide for doctors. Moscow: Medicine; 2008:200-235. (In Russ.).
  23. Twycross R. Factors of difficult-to-manage pain. Russian Scientific and Practical Journal PALLIUM, Palliative and Hospice Care. 2019. (In Russ.). Source: Indian J Palliative Care. 2004 Dec;10(2).
  24. Yakhno NN, Kukushkin ML, Davidov ML, Danilov AB, Amelin AV, Kulikov SM. Results of the Russian epidemiological study of the prevalence of neuropathic pain, its causes and characteristics in the population of outpatients who consulted a neurologist. Pain. 2008;3(20);24-32. (In Russ.).
  25. Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain. 2008;24(6):469-478. 
  26. Bannister K, Dickenson AH. Opioid hyperalgesia. Curr Opin Support Palliat Care. 2010;4:1-5. 
  27. Drews AM, Jensen RD, Nielsen LM, Droney J, Christrop LL, Arendt-Nielsen L, Riley J, Dahan A. Opioids: Pharmacological, experimental, clinical and economic considerations. British Journal of Clinical Pharmacology, 01 Jan 2013, 75(1): 60-78.  PMID:PMC3555047
  28. Bekkering GE, Soares-Weiser K, Reid K, Kessels AG, Dahan A, Treede RD, Kleijnen J. Can morphine still be considered to be the standard for treating chronic pain? A systematic review including pair-wise and network meta-analyses. Current Medical Research and Opinion. 2011 July;27(7):1477-1491. Epub 2011 June 02. PMID: 21635191. https://doi.org/10.1185/03007995.2011.586332
  29. Bemand-Qureshi L, Gishen F, Tookman A. Opioid use in palliative care: new developments and guidelines. The Prescriber. 2019 Apr:25-31. 
  30. Bennett MI, Rayment C, Hjermstad M, Aass N, Caraceni A, Kaasa S. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain. 2012 Feb;153(2):359-365. Epub 2011 Nov 23. PMID: 22115921. https://doi.org/10.1016/j.pain.2011.10.028
  31. Brookoff D. Abuse potential of various opioid medications. Journal of General Internal Medicine. 1993;8(12):688-690. 
  32. Mellar P. Davis, MD,FCCP, Pamela Gamier, RN, BSN, CHPN, Paul A. Sloan, MD General Pharmacology of Long-Acting, Extended-Release, and Sustained-Release Opioids for the Treatment of Chronic Nonmalignant Pain/ Journal of Opioid Management, vol.10,no7, May 2023, HYPERLINK “ https://doi.org/10.5055/jom.2014.0229.
  33. Butler SF, Black RA, Cassidy TA, Dailey TM, Budman SH. Abuse risks and routes of administration of different prescription opioid compounds and formulations. Harm Reduction Journal. 2011 Oct 19;8:29. PMID: 22011626; PMCID: PMC3213066. https://doi.org/10.1186/1477-7517-8-29
  34. Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, De Conno F, Fallon M, Hanna M, Haugen DF, Juhl G, King S, Klepstad P, Laugsand EA, Maltoni M, Mercadante S, Nabal M, Pigni A, Radbruch L, Reid C, Sjogren P, Stone PC, Tassinari D, Zeppetella G; European Palliative Care Research Collaborative (EPCRC); European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. The Lancet Oncology. 2012 Feb;13(2):e58-e68. PMID: 22300860. https://doi.org/10.1016/S1470-2045(12)70040-2
  35. Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symp Man. 2003;26(5):1026-1048.
  36. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O’Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009 Feb; 10(2):113-130. PMID: 19187889; PMCID: PMC4043401. https://doi.org/10.1016/j.jpain.2008.10.008
  37. Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain. 2006 Jan;7(1):43-48. PMID: 16414554. https://doi.org/10.1016/j.jpain.2005.08.001
  38. Coleman JJ, Schuster ChR, DuPont RL. Reducing the Abuse Potential of Controlled Substances. Pharmaceutical Medicine. 2010 Feb;24(1):21-36. 
  39. de Wit H, Bodker B, Ambre J. Rate of increase of plasma drug level influences subjective responses in humans. Psychopharmacology. 1992;107:352-358. 
  40. Dumas EO, Pollack GM. Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. The AAPS Journal. 2008 Dec;10(4): 537-551. Epub 2008 Nov 07. PMID: 18989788; PMCID: PMC2628209. https://doi.org/10.1208/s12248-008-9056-1
  41. Fishbain DA, Cole B, Lewis JE, Gao J, Rosomoff RS. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med. 2009;10:829-839. 
  42. Flemming K. The use of morphine to treat cancer-related pain: a synthesis of quantitative and qualitative research. J Pain Symptom Manage. 2010 Jan; 39(1):139-154. 
  43. Gálvez R, Pérez C. Is morphine still the best reference opioid? Pain Manag. 2012 Jan;2(1):33-45. 
  44. Gupta S, Atcheson R. Opioid and chronic non-cancer pain. Journal of Anaesthesiology, Clinical Pharmacology. 2013;29(1):6-12. 
  45. Gupta K. Iatrogenic angiogenesis. In: Morphine and Metastasis. Parat M, ed. Dordrecht, The Netherlands: Springer Science + Business Media; 2013:63-78. 
  46. Halbert BT, Davis RB, Wee CC. Disproportionate longer-term opioid use among U.S. adults with mood disorders. Pain. 2016 Nov;157(11):2452-2457. PMID: 27472400; PMCID: PMC5069117. https://doi.org/10.1097/j.pain.0000000000000650
  47. Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain. 2002; 18(4 Suppl):S3-S13. 
  48. Knapp CM, Ciraulo DA, Jaffe J. Opiates: clinical aspects. In: Lowinson JH, Ruiz P, Milman RB, Langrod JG, eds. Substance abuse. A comprehensive textbook. Philadelphia: Lippincott; 2005:180-195. 
  49. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011 Mar-Apr; 14(2):145-161. PMID: 21412369. ISSN 1533-3159.
  50. McCrorie C, Closs SJ, House A, Petty D, Ziegler L, Glidewell L, West R, Foy R. Understanding long-term opioid prescribing for non-cancer pain in primary care: a qualitative study. BMC Fam Pract. 2015 Sept 11;16:121. PMID: 26362559; PMCID: PMC4567803. https://doi.org/10.1186/s12875-015-0335-5
  51. Mitra S. Opioid-induced hyperalgesia: Pathophysiology and clinical implications. J Opioid Manage. 2008;4(3):123-130. 
  52. Nagi K, Piñeyro G. Regulation of opioid receptor signalling: Implications for the development of analgesic tolerance. Molecular Brain. 2011;4:25.  https://doi.org/10.1186/1756-6606-4-25
  53. Sjøgren P, Jensen NH, Jensen TS. Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain. 1994 Nov;59(2):313-316. PMID: 7892029.. https://doi.org/10.1016/0304-3959(94)90084-1
  54. South SM, Smith MT. Analgesic Tolerance to Opioids. PAIN. Clinical Updates. IASP. 2001;IX(5):1-4. 
  55. Zajaczkowska R, Leppert W, Mika J, Kocot-Kepska M, Woron J, Wrzosek A, Wordliczek J. Perioperative immunosupression and risk of cancer progression: The impact of opioids on pain management. Pain Res Manag. 2018;9293704.
  56. van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. J Pain Symptom Manage. 2016 June;51(6):1070-1090.e9. Epub 2016 Apr 23. PMID: 27112310. https://doi.org/10.1016/j.jpainsymman.2015.12.340
  57. Volkow ND, McLellan AT. Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies. New England Journal of Medicine. 2016 Mar 31;374(13):1253-1263. PMID: 27028915. https://doi.org/10.1056/NEJMra1507771
  58. Tawfik MO, Bryuzgin V, Kourteva G; FEN-INT-20 Study Group. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain. Curr Med Res Opin. 2004 Mar;20(3):259-267. PMID: 15025835. https://doi.org/10.1185/030079903125003026

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.